Insurance must cover Bioidentical hormones as they do pharmaceutical one

Summary

The bill mandates that any health insurance policy issued on or after Jan. 1, 2026 must pay for bioidentical hormone therapy when a licensed physician determines it is medically necessary. It applies to group accident and sickness plans, health‑care corporations, hospital service corporations, and health‑maintenance organizations, expanding coverage to patients who need these hormones.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share